CareDx Presents Landmark KOAR-1000 Data, Demonstrating Higher 1-Year Graft Survival and Reduction in Biopsies through ARTS Surveillance
CareDx, Inc. (CDNA)
Last caredx, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.caredxinc.com
Company Research
Source: GlobeNewswire
SOUTH SAN FRANCISCO, Calif., June 07, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced an analysis of one-year data from the first 1000 patients enrolled in the Kidney Outcomes with AlloSure Registry (KOAR) will be presented at the American Transplant Congress (ATC) 2021, which is taking place between June 4-9, 2021. The KOAR Study, which includes more than 1,500 kidney transplant patients from over 50 transplant centers, is the largest prospective study of AlloSure dd-cfDNA. Key findings from KOAR include: One-year graft survival among patients monitored with AlloSure was higher than those of patients reported in the national UNOS Registry DataAlloSure significantly reduces the number of biopsies performed when compared to biopsies guided by creatinineAlloSure d
Show less
Read more
Impact Snapshot
Event Time:
CDNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CDNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CDNA alerts
High impacting CareDx, Inc. news events
Weekly update
A roundup of the hottest topics
CDNA
News
- CareDx Appoints Bryan Riggsbee to Its Board of Directors [Yahoo! Finance]Yahoo! Finance
- CareDx Appoints Bryan Riggsbee to Its Board of DirectorsBusiness Wire
- CareDx, Inc (NASDAQ:CDNA) Q4 2023 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- CareDx (CDNA) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates [Yahoo! Finance]Yahoo! Finance
- CareDx Inc (CDNA) Surpasses Revenue Expectations Despite Net Loss Expansion in 2023 [Yahoo! Finance]Yahoo! Finance
CDNA
Earnings
- 2/28/24 - Beat
CDNA
Sec Filings
- 3/11/24 - Form 8-K
- 3/1/24 - Form POS
- 2/28/24 - Form 10-K
- CDNA's page on the SEC website